Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Pareesh Phulkar

Bookmark and Share
Transcatheter Embolization and Occlusion Devices Market 2026: Research Methodology
Transcatheter embolization and occlusion refers to passage or insertion of a synthetic embolus through a fine catheter in the blood vessel to obstruct the blood flow in particular area of the body.

BriefingWire.com, 9/13/2019 - Transcatheter embolization and occlusion refers to passage or insertion of a synthetic embolus through a fine catheter in the blood vessel to obstruct the blood flow in particular area of the body. Transcatheter embolization is a minimally invasive procedure performed as a part of interventional radiology to restrict blood supply to tumors. Synthetic materials known as embolic agents, in some cases, are coated with chemotherapeutic drug that perform dual action of blocking the blood supply as well as inducing cytotoxicity to the tumor in several ways. Moreover, this procedure is also employed to control or prevent abnormal bleeding, eliminate abnormal connections between arteries and veins as well as to treat aneurysms, which refers to formation of a bulge or a sac in weak arterial wall.

Transcatheter embolization is a less invasive and highly efficient way to control bleeding as compared to open invasive surgical procedures. Catheter embolization is considered to be the first line of treatment in gastrointestinal bleeding. This process can be performed alone or combined with other treatments such as surgery or radiation. The process is initiated with the help of x-ray imaging to visualize the blood vessel, after which an interventional radiologist inserts a catheter to the skin into the desired blood vessel and advanced to the treatment site. Among females, this method provides an excellent alternative to hysterectomy to shrink and control heavy menstrual bleeding by interrupting the blood supply caused due to uterine fibroid tumors.

Get PDF Brochure of This Business Report: https://www.coherentmarketinsights.com/insight/request-pdf/1683

Increasing demand for minimally invasive surgical procedures over conventional open surgeries is expected to propel growth of transcatheter embolization and occlusion devices market. This shift is a result of advantages offered by minimally invasive procedures over open surgeries that includes significantly low blood loss, low recovery time, low surgical time, reduced probability of errors, and others. For instance, according to a retrospective review published by Department of Surgery, John Hopkins Hospital, in 2014, it suggested that the complication and error rates for hysterectomy was 4.69% and 6.64% in catheter embolization and open surgical procedures,

respectively. Moreover, rising incidence of venous malformations leading to vascular anomalies is also an important factor contributing significantly to growth of the market. For instance, according to the International Society for Auricular Reconstruction, 2017, the incidence of venous malformations was reported to be 1-4% of the total world population, without any predilection in the However, practice of transcatheter embolization procedures without following FDA guidelines leading to increased hospital readmissions and requirement of expertise to perform the procedures is expected to hinder the market growth.

Browse more detail information about: https://www.coherentmarketinsights.com/ongoing-insight/transcatheter-embolization-and-occlusion-devices-market-1683

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2019 Proserve Technology, Inc.